Creative Biolabs has further strengthened its organ-specific targeted exosome modification platform to support advanced therapeutic development.
— As precision medicine continues to evolve, one of the biggest challenges in drug development remains unchanged: how to deliver therapeutic payloads to specific organs with high accuracy and minimal off-target effects.
Creative Biolabs’ site-specific exosome engineering enables targeted delivery by displaying functional ligands on exosomal membrane proteins, significantly improving tissue specificity and cellular uptake. Researchers and biotech companies can access customizable exosome engineering strategies through Creative Biolabs to accelerate preclinical research and translational studies.
Crossing the Blood–Brain Barrier with Engineered Exosomes
The blood–brain barrier (BBB) remains one of the most significant obstacles in treating central nervous system disorders.
RVG- or ApoE-modified exosomes enable efficient BBB penetration via receptor-mediated transcytosis, allowing targeted delivery to neuronal cells. Creative Biolabs applies genetic fusion strategies by linking targeting peptides to exosomal membrane proteins such as Lamp2b, ensuring stable and high-density ligand display.
Expert Insight: “We aren’t just coating the surface,” explains a senior scientist at Creative Biolabs. “Our method ensures the stable, high-density display of ligands. This is crucial because low-affinity binding often leads to exosomes being trapped in the brain’s endothelial cells rather than reaching the neurons. Our optimized peptide-Lamp2b constructs have demonstrated a 3- to 5-fold increase in CNS accumulation in preclinical models.”
For CNS-targeted delivery projects, Creative Biolabs provides customizable brain-targeted exosome modification solutions, from ligand design to functional validation.
Precision Oncology: Moving Beyond Passive Targeting
In oncology, traditional passive targeting strategies often fail to deliver consistent results in solid tumors.
Engineered exosomes achieve active tumor targeting by incorporating ligands such as anti-HER2 scFv or nucleic acid aptamers, enabling receptor-specific uptake. This triggers clathrin-mediated endocytosis and facilitates efficient intracellular delivery.
By using Creative Biolabs’ platform, therapeutic payloads—including siRNA, miRNA, and CRISPR/Cas9 systems—can be delivered directly into the cytoplasm, bypassing lysosomal degradation and significantly reducing systemic toxicity.
Creative Biolabs supports breast cancer-targeted exosome engineering projects with flexible design options tailored to different tumor biomarkers and therapeutic modalities.
Lung and Liver Targeting: Overcoming Rapid Clearance
Targeting organs such as the lungs and liver requires overcoming rapid clearance by the reticuloendothelial system (RES).
PEGylation combined with targeting ligand conjugation allows exosomes to evade immune clearance while maintaining organ specificity. Creative Biolabs employs a dual “de-targeting + re-targeting” strategy to enhance delivery efficiency.
For pulmonary delivery, specific peptides guide exosomes to lung tissues.
For hepatic targeting, GalNAc-modified exosomes bind to ASGPR receptors, enabling highly selective hepatocyte uptake.
Creative Biolabs offers dedicated solutions for lung- and liver-targeted delivery, supporting gene therapy and RNA-based therapeutics development.
Key Advantages of Creative Biolabs’ Exosome Engineering Platform
High specificity through site-specific ligand display
Improved delivery efficiency across biological barriers such as the BBB
Reduced immune clearance via optimized surface modification
Flexible payload compatibility, including RNA, proteins, and gene-editing systems
End-to-end service support, from design to functional validation
Start your project with Creative Biolabs today and explore tailored exosome engineering solutions for your specific research needs.
About
Creative Biolabs is a leading biotechnology service provider specializing in exosome research and engineering. The company offers comprehensive solutions, including exosome isolation, surface modification, cargo loading, and functional validation, supporting both academic and pharmaceutical innovation worldwide.
Contact Info:
Name: Candy Swift
Email: Send Email
Organization: Creative Biolabs
Website: https://www.creative-biolabs.com/exosome/
Release ID: 89189515
If you detect any issues, problems, or errors in this press release content, kindly contact error@releasecontact.com to notify us (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). We will respond and rectify the situation in the next 8 hours.